login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NEUROPACE INC (NPCE) Stock News
USA
- NASDAQ:NPCE -
US6412881053
-
Common Stock
12.81
USD
-0.69 (-5.11%)
Last: 11/13/2025, 8:00:02 PM
12.8
USD
-0.01 (-0.08%)
After Hours:
11/13/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NPCE Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Chartmill
- Mentions:
EVC
RUBI
BW
SONN
...
These stocks are moving in today's session
9 days ago - By: Chartmill
- Mentions:
RIGL
EVC
RUBI
BW
...
Keep an eye on the top gainers and losers in Wednesday's session.
5 days ago - By: The Motley Fool
NeuroPace (NPCE) Q3 2025 Earnings Call Transcript
9 days ago - By: Benzinga
- Mentions:
PRGO
RIGL
DAWN
SUPN
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
9 days ago - By: Benzinga
- Mentions:
QS
FUBO
MRVL
LMND
...
Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday
9 days ago - By: Chartmill
- Mentions:
WWW
RIGL
EVC
TREX
...
Wednesday's session: gap up and gap down stocks
9 days ago - By: Zacks Investment Research
- Mentions:
GMED
NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates
9 days ago - By: Chartmill
- Mentions:
RIGL
TREX
CDNA
APPS
...
What's going on in today's after hours session
10 days ago - By: NeuroPace, Inc.
NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
23 days ago - By: NeuroPace, Inc.
NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025
3 months ago - By: NeuroPace, Inc.
NeuroPace to Participate in Upcoming Healthcare Conferences
3 months ago - By: The Motley Fool
NeuroPace Revenue Jumps 22 Percent in Q2
3 months ago - By: Zacks Investment Research
- Mentions:
ARAY
NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates
3 months ago - By: NeuroPace, Inc.
NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
3 months ago - By: Zacks Investment Research
- Mentions:
STXS
Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates
3 months ago - By: Zacks Investment Research
- Mentions:
PRCT
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates
3 months ago - By: Zacks Investment Research
- Mentions:
OFIX
Orthofix (OFIX) Q2 Earnings and Revenues Beat Estimates
3 months ago - By: NeuroPace, Inc.
NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases
4 months ago - By: NeuroPace, Inc.
NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025
4 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
5 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
5 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
5 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
5 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
5 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
5 months ago - By: NeuroPace, Inc.
NeuroPace Announces Strategic CFO Transition
5 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
5 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
5 months ago - By: The Schall Law Firm
NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm
5 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
5 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
5 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
5 months ago - By: Yahoo Finance
NeuroPace, Inc. (NPCE) Backed by Cantor Fitzgerald Following Physician Survey
5 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
Please enable JavaScript to continue using this application.